APA

Pol S., Haour G., Fontaine H., Dorival C., Petrov-Sanchez V., Bourliere M., Capeau J., Carrieri P., Larrey D., Larsen C., Marcellin P., Pawlostky J., Nahon P., Zoulim F., Cacoub P., de Ledinghen V., Mathurin P., Negro F., Pageaux G., Yazdanpanah Y., Wittkop L., Zarski J. & Carrat F. (20180205). The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. : Alimentary pharmacology & therapeutics.

Chicago

Pol S, Haour G, Fontaine H, Dorival C, Petrov-Sanchez V, Bourliere M, Capeau J, Carrieri P, Larrey D, Larsen C, Marcellin P, Pawlostky J-M, Nahon P, Zoulim F, Cacoub P, de Ledinghen V, Mathurin P, Negro F, Pageaux G-P, Yazdanpanah Y, Wittkop L, Zarski J-P and Carrat F. 20180205. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. : Alimentary pharmacology & therapeutics.

Harvard

Pol S., Haour G., Fontaine H., Dorival C., Petrov-Sanchez V., Bourliere M., Capeau J., Carrieri P., Larrey D., Larsen C., Marcellin P., Pawlostky J., Nahon P., Zoulim F., Cacoub P., de Ledinghen V., Mathurin P., Negro F., Pageaux G., Yazdanpanah Y., Wittkop L., Zarski J. and Carrat F. (20180205). The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. : Alimentary pharmacology & therapeutics.

MLA

Pol S, Haour G, Fontaine H, Dorival C, Petrov-Sanchez V, Bourliere M, Capeau J, Carrieri P, Larrey D, Larsen C, Marcellin P, Pawlostky J-M, Nahon P, Zoulim F, Cacoub P, de Ledinghen V, Mathurin P, Negro F, Pageaux G-P, Yazdanpanah Y, Wittkop L, Zarski J-P and Carrat F. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. : Alimentary pharmacology & therapeutics. 20180205.